机构:[1]Key Laboratory of Animal Models and Human Disease Mechanisms of CAS and Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China[2]Glycotope GmbH, Berlin-Buch, Germany[3]Department of General Surgery,First Affiliated Hospital of Kunming Medical College,Kunming,China外科科室昆明医科大学附属第一医院
P>The cancer-initiating capacity of most malignant tumours is considered to reside in a small subpopulation of cells. Therapeutical interventions should target these cells rather than the tumour mass. Numerous studies have shown that the carbohydrate antigen structure CD176 (Thomsen-Friedenreich antigen, core-1) is present in many types of cancer and absent in normal adult human tissues. In this study, we assessed whether CD176 is co-expressed with CD44 or CD133 [markers of cancer-initiating cells (CIC)] in human lung, breast and liver carcinoma. A variety of human cancer cell lines and surgical specimens of these malignancies were examined. It was found that in most cases the majority of tumour cells stained strongly for CD44 by immunohistochemistry and flow cytometry, whereas CD133 expression was found on a smaller, but varying proportion of cells. Co-expression of CD176 with CD44 was found at a surprisingly high percentage of cancer cells in vitro and in vivo. Co-expression of CD176 with CD133 was also detected, although at a lower rate. Tamoxifen treatment of MDA-435 breast cancer cells enhanced the CD44+/CD176+ phenotype. Evidence is provided through a new sandwich solid-phase enzyme-linked immunosorbent assay (ELISA) suggesting that CD44 is a carrier molecule for CD176 not only in colorectal cancer as previously reported, but also in lung, breast and liver cancer. The expression of CD176 in CIC suggests that it may represent an effective target for tumour therapies.
基金:
Yunnan Province Science and Technology DepartmentNatural Science Foundation of Yunnan Province [2008CCO15]
第一作者机构:[1]Key Laboratory of Animal Models and Human Disease Mechanisms of CAS and Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China
通讯作者:
通讯机构:[*1]Key Laboratory of Animal Models and Human Disease Mechanisms of CAS and Yunnan Province Kunming Institute of Zoology Chinese Academy of Sciences 32 Jiaochang Donglu Kunming Yunnan 650223 China
推荐引用方式(GB/T 7714):
Lin Wei-Ming,Karsten Uwe,Goletz Steffen,et al.Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells[J].INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY.2011,92(2):97-105.doi:10.1111/j.1365-2613.2010.00747.x.
APA:
Lin, Wei-Ming,Karsten, Uwe,Goletz, Steffen,Cheng, Ruo-Chuan&Cao, Yi.(2011).Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells.INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY,92,(2)
MLA:
Lin, Wei-Ming,et al."Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells".INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY 92..2(2011):97-105